CHRNA5 and breast neoplasm: Previous studies have shown that incorporation or exclusion of CHRNA5 from the cholinergic receptor’s pentameric structure can modulate intracellular calcium levels [93, 94]; future studies in this direction could provide novel insights about the mechanisms of action by which CHRNA5 depletion works in breast tumors.